XML 31 R20.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share-Based Payments: (Tables)
3 Months Ended
Mar. 31, 2024
Equity:  
The following table sets forth information with respect to nonvested options for the three months ended March 31, 2024:

The following table sets forth information with respect to nonvested options for the three months ended March 31, 2024:

 

   Number of Shares   Weighted Average Grant-Date Fair Value 
Nonvested options – beginning of period   122,100   $24.47 
Nonvested options granted        
Nonvested options vested or forfeited   (3,140)  $11.86 
Nonvested options – end of period   118,960   $24.80 
The following table summarizes stock option information as of March 31, 2024:

The following table summarizes stock option information as of March 31, 2024:

 

   Shares   Weighted Average
Exercise Price
 
         
Outstanding at January 1, 2024   308,970   $86.52 
Options forfeited   (140)   73.09 
Options exercised   (18,980)   69.87 
           
Outstanding at March 31, 2024   289,850   $87.62 
           
Options exercisable   170,890   $70.60 
Options available for future grants   537,505      
Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the three months ended March 31, 2024 and 2023 were as follows:

Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the three months ended March 31, 2024 and 2023 were as follows:

 

(In thousands)  March 31,
2024
   March 31,
2023
 
         
Cash proceeds from stock options exercised  $1,326   $4,929 
Tax benefits   220    780 
Intrinsic value of stock options exercised   1,375    5,403